4.6 Editorial Material

More is better? Hypertonic saline dose and response for cystic fibrosis: efficacy, tolerability and implications for clinical practice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Critical Care Medicine

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett et al.

Summary: The SIMPLIFY study aimed to assess the effects of discontinuing nebulised hypertonic saline or dornase alfa in people using CFTR modulator therapy. The study found that discontinuing these treatments for 6 weeks did not result in clinically meaningful differences in pulmonary function compared to continuing treatment in individuals with relatively well-preserved lung function.

LANCET RESPIRATORY MEDICINE (2023)

Article Respiratory System

Saline at lower tonicity in cystic fibrosis (SALTI-CF) trial comparing 0.9% versus 3% versus 6% nebulised saline

Tiffany J. Dwyer et al.

Summary: This study evaluated the relative effectiveness and tolerability of different concentrations of saline nebulised twice daily in cystic fibrosis patients. The results showed that 3% saline significantly improved lung function and delayed pulmonary exacerbations, while 6% saline had similar benefits and also improved quality of life. However, the positive impacts of 6% saline on time to intravenous antibiotics for exacerbations and quality of life were not maintained.

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Critical Care Medicine

The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial

Harm A. W. M. Tiddens et al.

Summary: A multicentre study demonstrated that inhaled hypertonic saline had a positive effect on structural lung changes in children aged 3-6 years with cystic fibrosis compared to isotonic saline.

LANCET RESPIRATORY MEDICINE (2022)

Article Critical Care Medicine

Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS) A Randomized, Double-Blind, Controlled Study

Mirjam Stahl et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Respiratory System

The in vitro effect of nebulised hypertonic saline on human bronchial epithelium

Jennifer L. Goralski et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

Article Respiratory System

Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis

Aaron T. Trimble et al.

JOURNAL OF CYSTIC FIBROSIS (2018)

Article Medicine, Research & Experimental

Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure

Ashley G. Henderson et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Biochemistry & Molecular Biology

Hypertonic Saline Is Effective in the Prevention and Treatment of Mucus Obstruction, but Not Airway Inflammation, in Mice with Chronic Obstructive Lung Disease

Simon Y. Graeber et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)

Article Medicine, General & Internal

Mucus clearance and lung function in cystic fibrosis with hypertonic saline

SH Donaldson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

MR Elkins et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)